RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 76 filers reported holding RECRO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $36,000 | -52.0% | 17,473 | -45.9% | 0.00% | – |
Q2 2021 | $75,000 | -55.4% | 32,318 | -46.3% | 0.00% | – |
Q1 2021 | $168,000 | -3.4% | 60,218 | -1.3% | 0.00% | – |
Q4 2020 | $174,000 | +67.3% | 60,995 | +23.4% | 0.00% | – |
Q3 2020 | $104,000 | -36.2% | 49,435 | +37.7% | 0.00% | – |
Q2 2020 | $163,000 | -70.3% | 35,892 | -46.5% | 0.00% | -100.0% |
Q1 2020 | $548,000 | -78.8% | 67,133 | -52.4% | 0.00% | -50.0% |
Q4 2019 | $2,585,000 | +118.1% | 141,045 | +31.9% | 0.00% | +100.0% |
Q3 2019 | $1,185,000 | +9.4% | 106,909 | +0.4% | 0.00% | 0.0% |
Q2 2019 | $1,083,000 | +109.9% | 106,533 | +21.1% | 0.00% | – |
Q1 2019 | $516,000 | -15.8% | 87,989 | +1.9% | 0.00% | -100.0% |
Q4 2018 | $613,000 | +0.2% | 86,382 | +0.3% | 0.00% | 0.0% |
Q3 2018 | $612,000 | +230.8% | 86,095 | +134.2% | 0.00% | – |
Q2 2018 | $185,000 | -16.3% | 36,760 | +83.3% | 0.00% | – |
Q1 2018 | $221,000 | +40.8% | 20,055 | +18.2% | 0.00% | – |
Q4 2017 | $157,000 | +6.1% | 16,968 | +3.3% | 0.00% | – |
Q3 2017 | $148,000 | – | 16,428 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |